Clinical Trials Browser

Phase 2 × Recurrent Endometrial Endometrioid Adenocarcinoma × Clear all

NCT02684227 2025-03-19

Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer

Phase 2 Completed

50 enrolled 14 charts

Recurrent Endometrial Endometrioid Adenocarcinoma